Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)famotidine complex

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 25, Issue 3, 2010, Pages 383-390

  Amin, Muhammad ^a,b   Iqbal, Mohammad S ^c   Hughes, Roy W ^b   Khan, Safyan A ^b   Reynolds, Paul A ^b   Enne, Virve I ^b   Sajjad ur Rahman, ^d   Mirza, Akmal S ^e  

^a UNIVERSITY OF SARGODHA   (Pakistan)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c GC UNIVERSITY   (Pakistan)

^d UNIVERSITY OF AGRICULTURE   (Pakistan)

^e PUNJAB MEDICAL COLLEGE   (Pakistan)

Author keywords

Anti H. pylori activity; Antiulcer drugs; Mechanochemical synthesis; Metal based drugs; Urease inhibition; Zinc complexes; Zinc famotidine

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FAMOTIDINE; METRONIDAZOLE; TETRACYCLINE; UNCLASSIFIED DRUG; UREASE; ZINC COMPLEX; ZINC FAMOTIDINE COMPLEX;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DERIVATIZATION; DRUG SYNTHESIS; ENZYME INHIBITION; GROWTH INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LD 50; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; TOXICITY TESTING;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG RESISTANCE, MICROBIAL; FAMOTIDINE; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; UREASE; ZINC;

HELICOBACTER PYLORI;

EID: 77951465434     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756360903179518     Document Type: Article

References (35)

1. Kubiak M, Duda AM, Ganadu ML, Kozlowski H. Crystal structure of a copper(II)-famotidine complex and solution studies of the Cu2+- famotidinehistidine ternary system. J Chem Soc Dalton Trans 1996:1905-1908.
2. Baranska M, Lasocha W, Kozlowski H, Proniewicz LM. New solid state Ni(II)-famotidine square-planar complex: powder diffraction and spectroscopic studies. J Inorg Biochem 2004;98:995-1001.
3. Djenana UM, Bogdanovic GA, Miodragovic ZM, Radulovic MD, Novakovic SB, Kaluderovic GNH, et al. Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex. J Inorg Biochem 2006;100:1568-1574
4. Merck Index, 13th ed. O'Neil MJ, Smith A, Heckelman PE. Whitehouse Station, NJ: Merck & Co., 2001.
5. Martindale: The Complete Drug Reference, 35th ed. Seetman SC. London: Pharmaceutical Press, 2006.
6. Andrews M, Gallagher-Allred C. The role of zinc in wound healing. Adv Wound Care 1999;12:137-138
7. Ito M, Inaguma K, Suzuki Y, Segami T, Suzuki Y. Healing-promoting action of the zinc-cimetidine complex on acetic acid-induced gastric ulcers in Rats. Jpn J Pharmacol 1995;68:287-295.
8. Conchillo A, Mola C, Navarro C, Bravo L, Bulbena Q. Cytoprotective and antisecretory activity of a ranitidine-zinc complex. Prost Leuko Essen Fatty Acids 1995;52:393-397
9. International Conference on Harmonisation. Q3C: Impurities: guideline for residual solvents, Step 4, July 1997. Geneva: ICH, 1997.
10. Gary AL, Pichon A, James SL. Solvent-free synthesis of metal complexes. Chem Soc Rev 2007;84:636.
11. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-741
12. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Shortterm low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol 1994;6:773-777
13. Cruickshank R, Duguid JP, Marmion BP, Swain RHA. Medical Microbiology, 12th ed. Edinburgh: McGraw-Hill, 1975:109-112
14. Megraud F, Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller R, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43:2747-2752
15. Wu H, Shi D, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxicillin. J Antimicrob Chemother 2000;46:121-123
16. Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4- triazole-3(4H)-thiones. ARKIVOC 2009;(vii):210-221
17. Akhter T, Hameed S, Khan KM, Choudhry MI. Synthesis, urease inhibition, and antimicrobial studies of some chiral 3-substituted-4-amino-5-thioxo-1H,4H-1, 2,4-triazole. Med Chem 2008;4: 539-543
18. Perveen S, Khan KM, Lodhi MA, Choudhary MI, Atta-ur-Rahman, Voelter W. Urease and chymotrypsin inhibitory effects of selected urea derivatives. Lett Drug Des Discov 2008;5:401-405
19. Zaheer-ul-Haq, Lodhi MA, Nawaz SA, Iqbal S, Khan KM, Rode BM, et al. 3D-QSAR CoMFA sudies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents. Bioorg Med Chem 2008;16:3456-3461
20. Pervez H, Iqbal MS, Tahir MY, Nasim FU, Choudhary MI, Khan KM. In vitro cytotoxic, antibacterial, antifungal and urease inhibitory activities of some N4-substituted isatin-3-thiosemicarbazones. J Enzyme Inhib Med Chem 2008;23:848-854
21. Amtul Z, Follmer C, Mahboob S,Atta-ur-Rahman, Mazhar M, Khan KM, et al. Germa lactones as novel inhibitors of bacterial urease activity. Biochem Biophys Res Commun 2007;356:457-463
22. Jamal RA, Ashiq U, Tahir MM, Maqsood ZT, Khan KM, Lodhi MA, et al. Chemistry, urease inhibition, and phytotoxic studies of binuclear vanadium (IV) complexes. Chem Biodiver 2007;4:58-71.
23. Khan KM, Zia-Ullah, Lodhi MA, Ali M, Choudhary MI, Atta-ur-Rahman, et al. Successful computer guided planned synthesis of (4R)-thiazolidine carboxylic acid and its 2-substituted analogues as urease inhibitors. Mol Divers 2006;10:223-231
24. Amtul Z, Kausar N, Follmer C, Rozmahel RF, Atta-ur-Rahman, Kazmi SA, et al. Cytseine based novel noncompetitive inhibitors of urease(s)-distinctive inhibition susceptibility of microbial and plant ureases. Bioorg Med Chem 2006;14:6737-6744
25. Khan KM, Zafar SS, Lodhi MA, Butt N, Perveen S, Maharvi GM, et al. Piperidines: a new class of urease inhibitors. Nat Prod Res 2006;20:523-530 (Pubitemid 43731127)
26. Khan KM, Iqbal S, Lodhi MA, Maharvi GM, Perveen S, Choudhary MI, et al. Synthesis and urease enzyme inhibitory effects of some dicoumarols. J Enzyme Inhib Med Chem 2004;19:367-372
27. Khan KM, Iqbal S, Lodhi MA, Maharvi GM, Zia-Ullah, Choudhary MI, et al. Biscoumarine: new class of urease inhibitors; economical synthesis and activity. Bioorg Med Chem 2004;12:1963-1968
28. Amtul Z, Rasheed M, Choudhary MI, Rosanna S, Khan KM, Atta-ur-Rahman. Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biochem Biophys Res Commun 2004;319:1053-1063
29. Weatherburn MW. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem 1967;39:971-974
30. Nagata K, Mizuta T, Tonokatu Y, Fukuda Y, Okamura H, Hayashi T, et al. Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immunol 1992;60:4826-4831
31. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497
32. www.sciencelab.com
33. Walsh CT, Sandstead HH, Prasad AS, Newberne PM Fraker PJ. Zinc: health effects and research priorities for the 1990s. Environ Health Perspect 1994;102:5-46.
34. Rainsford KD, Goldie J, Hunt RH. Zinc compounds combined with cyclodextrin inhibit growth of Helicobacter pylori in-vitro. Pharm Sci 1997;3:483-485
35. Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:451-480